1 Min Read
Aug 8 (Reuters) - Stemline Therapeutics Inc:
* Stemline Therapeutics Inc files for mixed shelf offering of up to $175 million - SEC filing Source text: (bit.ly/2wFKm1k) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.